当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3843130
已选条件
-
T77466Tremelimumab;曲美木单抗Ticilimumab|||CP-675206;Ticilimumab|||CP-675206
Tremelimumab is a cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blocking antibody.Tremelimumab is often used in combination with Durvalumab for the treatment of solid cancers such as hepatocellular carcinoma and lung cancer.
价 格:¥电议型 号:T77466产 地:中国大陆
-
T77439Glembatumumab;格巴妥木单抗Glembatumumab
Glembatumumab is a fully human IgG2 monoclonal antibody targeting the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma.Glembatumumab is a naked antibody to Glembatumumab vedotin and can be used to study antibody-activated molecule couplings (Glembatumumab vedotin ).
价 格:¥电议型 号:T77439产 地:中国大陆
-
T77057Lerdelimumab;化合物 LerdelimumabLerdelimumab
Lerdelimumab (CAT-152) is a recombinant human monoclonal antibody of the IgG4 subclass targeting TGF-β2. It holds potential as an anti-scarring agent in glaucoma research [1] [2].
价 格:¥电议型 号:T77057产 地:中国大陆
-
T77041Iratumumab;化合物 IratumumabIratumumab
Iratumumab (MDX-060), a human anti-CD30 IgG1κ monoclonal antibody, inhibits the growth of CD30-expressing tumor cells and is utilized in the research of Hodgkin´s lymphoma (HL) and anaplastic large-cell lymphoma (ALCL) [1].
价 格:¥电议型 号:T77041产 地:中国大陆
-
T77029Gremubamab;化合物 GremubamabGremubamab
Gremubamab (MEDI3902), a humanized IgG1 kappa anti-PcrV/Psl monoclonal antibody, specifically targets and binds to the Pseudomonas aeruginosa PcrV protein and Psl exopolysaccharide. It shows promise for the study of Pseudomonas aeruginosa infections [1] [2].
价 格:¥电议型 号:T77029产 地:中国大陆
-
T76957Belimumab;贝利尤单抗LymphoStat B;LymphoStat B
Belimumab(LymphoStat B) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF).Belimumab is used in the study of fatigue and in the treatment of lupus nephritis and systemic lupus erythematosus.
价 格:¥电议型 号:T76957产 地:中国大陆
-
T76944Cergutuzumab amunaleukin;化合物 Cergutuzumab amunaleukinCergutuzumab amunaleukin
Cergutuzumab amunaleukin (CEA-IL2v), a monomeric immunocytokine, targets carcinoembryonic antigen (CEA) and is based on an IL-2 variant. It exhibits immunostimulating and antineoplastic activities.
价 格:¥电议型 号:T76944产 地:中国大陆
-
T76928Bertilimumab;化合物 BertilimumabBertilimumab
Bertilimumab (CAT 213; iCo-008), a human monoclonal antibody that targets eotaxin-1 (CCL11), shows promise in the research of allergic disorders [1].
价 格:¥电议型 号:T76928产 地:中国大陆
-
T76912Atorolimumab;化合物 AtorolimumabAtorolimumab
Atorolimumab (P3x22914G4), a monoclonal antibody, is employed in immunotherapies that target the programmed death-1 (PD-1) receptor [1].
价 格:¥电议型 号:T76912产 地:中国大陆
-
T76904Amubarvimab;化合物 AmubarvimabAmubarvimab
Amubarvimab (BRII-196), a human IgG1 monoclonal antibody (mAb), targets non-competing epitopes on the receptor binding domain (RBD) of the spike protein, exhibiting a dissociation constant (K D) of 5.88 nM. It has demonstrated efficacy in neutralizing SARS-CoV-2 variants [1] [2].
价 格:¥电议型 号:T76904产 地:中国大陆
-
T76898Adalimumab beta;化合物 Adalimumab betaAdalimumab beta
Adalimumab beta (ABP-501) is an anti-TNF-α monoclonal antibody utilized in the study of rheumatoid arthritis (RA) [1].
价 格:¥电议型 号:T76898产 地:中国大陆
-
T76833Tomuzotuximab;化合物 TomuzotuximabTomuzotuximab
Tomuzotuximab, a fully human glycoengineered IgG1 monoclonal antibody targeting EGFR (Anti-Human EGFR Recombinant Antibody), exhibits anticancer effects [1].
价 格:¥电议型 号:T76833产 地:中国大陆
-
T76819Metelimumab;化合物 MetelimumabMetelimumab
Metelimumab (CAT-192), a human IgG4 monoclonal antibody, selectively neutralizes TGFβ1 [1].
价 格:¥电议型 号:T76819产 地:中国大陆
-
T76815Lexatumumab来沙木单抗ETR2-ST01|||DR5 mAB|||HGS-ETR 2
Lexatumumab (GHS-ETR 2) is a human excitatory monoclonal antibody targeting TRAIL receptor 2 that has anticancer activity and induces apoptosis in malignant mesothelioma. Lexatumumab can be used to study malignant pleural mesothelioma (MPM).
价 格:¥电议型 号:T76815产 地:中国大陆
-
T76812Intetumumab;化合物 IntetumumabIntetumumab
Intetumumab (CNTO 95), a glycoengineered anti-EGFR monoclonal antibody designed for improved antibody-dependent cellular cytotoxicity (ADCC), is utilized in cancer research [1] [2].
价 格:¥电议型 号:T76812产 地:中国大陆
-
T76787Conatumumab;西他土珠TRAIL-R2 mAb|||AMG 655;TRAIL-R2 mAb|||AMG 655
Conatumumab (AMG 655) is a monoclonal agonist antibody targeting human death receptor 5 (DR5, TRAILR2) at Kd 1 nM for long DR5 and Kd 0.8 nM for short DR5. Conatumumab induces apoptosis in a variety of tumor types through caspase activation. Conatumumab can be used to study advanced solid tumors.
价 格:¥电议型 号:T76787产 地:中国大陆
-
T76782Mogamulizumab;莫格利珠单抗KW-0761;KW-0761
Mogamulizumab (KW-0761) is a monoclonal antibody against T cell CC chemokine receptor 4. Mogamulizumab has anticancer activity, eliminating tumor cells through antibody dependent cytotoxicity (ADCC), and can be used to study cancer, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL).
价 格:¥电议型 号:T76782产 地:中国大陆
-
T76760Sifalimumab;西法木单抗MDX-1103|||MEDI-545;MDX-1103|||MEDI-545
Sifalimumab (MEDI-545) is a monoclonal antibody that targets IFNα and suppresses abnormal immune activity by binding to interferon-alpha.Sifalimumab is used for the treatment of moderate to severe SLE.
价 格:¥电议型 号:T76760产 地:中国大陆
-
T76759Robatumumab;化合物 RobatumumabRobatumumab
Robatumumab (Sch 717454), an anti-human insulin-like growth factor receptor-1 (IGF-1R) antibody, exhibits anti-tumor and anti-proliferative effects on cancer cells. It is applicable in research concerning osteosarcoma and Ewing sarcoma [1] [2].
价 格:¥电议型 号:T76759产 地:中国大陆
-
T76758Rilotumumab;利妥木单抗AMG 102;AMG 102
Rilotumumab (AMG 102) is a monoclonal antibody targeting hepatocyte growth factor that inhibits HGF/ MET-driven signaling. Rilotumumab has antitumor effects and can be used to study castration-resistant prostate cancer (CRPC) and gastric cancer.
价 格:¥电议型 号:T76758产 地:中国大陆